To evaluate the effects of antihypertensive agents on Captopril (12.5 mg) twice daily (n = 15) produced a mild reduction in BP with little change in the circadian patthe circadian blood pressure (BP) of patients with previous brain infarction, the ambulatory BP was measured tern. The slow-release nifedipine group had the greatest decrease in mean systolic and diastolic BP. The heart non-invasively for 24 h before and after administration of antihypertensive agents. One hundred milligrams of rate significantly increased after administration of slowrelease nifedipine and decreased after administration of acebutolol twice daily (n = 15) is effective in lowering the BP during the daytime, but has little effect during acebutolol. To reduce stroke recurrence, we should consider the effects of antihypertensive agents on circadian the night and the morning. Twenty milligrams of slowrelease nifedipine twice daily (n = 14) produced a con-BP in hypertensive patients with previous brain infarction. sistent reduction in the BP over the entire 24-h period and effectively blunted the rise in BP in the morning.
Introduction
brain infarction at least a month prior to the study Previous studies have shown that the blood pressure in patients with diastolic BP (DBP) between 95 and (BP) fluctuates during the day. With improvements 114 mg Hg on three occasions. Patients with atrial in the technical equipment, non-invasive 24-h fibrillation, severe heart disease, significant renal ambulatory BP monitoring (ABPM) is now widely disease, and significant liver disease were excluded used for the diagnosis and therapy of hypertension.
from the study. The 19 patients who were recruited Antihypertensive therapy is generally recfor this study, all had 24-h ambulatory BP readings ommended for hypertensive patients with previous higher than 135 mm Hg systolic and higher than 80 brain infarction to reduce stroke recurrence.
1,2 mm Hg diastolic. Some patients had not been treated Although it is postulated that an excessive nocturnal before and some had not been treated for at least 4 reduction in BP in patients with cerebrovascular disweeks. Informed consent for this study was obtained ease may provoke stroke recurrence, 3 there is little from each patient. Patients were treated with either information concerning the effects of antihypertenacebutolol 100 mg twice daily (n = 15), slow-release sive agents on circadian BP changes in hypertensive nifedipine 20 mg twice daily (n = 14) or captopril patients with previous brain infarction. Therefore, 12.5 mg twice daily (n = 16) with cross-over study we undertook a comparison of the effects of three designs. However, a complete cross-over study different antihypertensive agents (acebutolol, slowdesign could not be performed, so the patients were release nifedipine and captopril) on ambulatory BP. treated as follows. Seven out of the 19 were treated with either acebutolol, slow-release nifedipine or captopril. Three were treated with either acebutolol
Patients and methods
or slow-release nifedipine, five with either acebutoThe ambulatory BP and heart rate were non-invaslol or captopril and four with either slow-release ively measured every hour for 24 h by an oscillonifedipine or captopril. Clinical characteristics of metric method using an ABPM 630 (Nippon Colin, the patients in this study are shown in (midnight to 5 am), morning (6 am to 11 am), day-
Figure 1
The daily profiles in the BP and heart rate before and after acebutolol treatment. SBP before (ć) and after (b) acebutolol time (noon to 5 pm) and evening (6 pm to 11 pm).
treatment, DBP before (˿) and after () acebutolol treatment and
To evaluate the effect of antihypertensive agents heart rate before (᭝) and after (̆) acebutolol treatment are shown.
on circadian BP or heart rate of each patient, the standard deviation from the mean of all systolic BP (SBP), DBP and heart rate readings was calculated shown in Figures 1, 2 and 3 , respectively. The for the day. Given that the standard deviation is changes in the BP and heart rate after administration affected by the average BP or heart rate, we examof acebutolol, slow-release nifedipine and captopril ined the variability indexes with the following forin each period are shown in Figures 4, 5 and 6, mula.
respectively. Acebutolol produced a significant reduction in the The variability index (%) = BP during the period from noon to 11 pm and in the heart rate from noon to 5 pm. However there was no The standard deviation of BP or heart rate Average BP or average heart rate × 100 reduction in the BP during the period from midnight to 11 am. The slow-release nifedipine produced conSince the BP is registered by oscillometry, 95% of sistent and significant reductions in BP over the total attempted BP checks were successfully recorded.
The data were analysed using the Student's paired and non-paired t-test.
Results
The results of the 24-h ambulatory BP and heart rate checks are listed in Table 2 . Before treatment, there were no significant differences among SBP, DBP and heart rate readings in any of the three groups. However, the SBP and DBP rates significantly decreased in all three groups after treatment. The greatest decrease in the mean was systolic and diastolic BP in the slow-release nifedipine group. The heart rate was significantly increased after the administration Figure 2 The daily profiles in the BP and heart rate before and of slow-release nifedipine and decreased after after slow-release nifedipine treatment. SBP before (ć) and after administration of acebutolol. The daily profiles of (b) slow-release nifedipine treatment, DBP before (ᮀ) and after BP and heart rate before and after acebutolol, slow-() slow-release nifedipine treatment and heart rate before (᭝) and after (̆) slow-release nifedipine treatment are shown. release nifedipine and captopril treatment are SBP: systolic blood pressure; DBP: diastolic blood pressure; HR: heart rate; *P Ͻ0.05 and **P Ͻ0.01 vs before treatment.
Figure 6
The changes of the BP and heart rate at four periods after administration of captopril. Figure 3 The daily profiles in the BP and heart rate before and after captopril treatment. SBP before (ć) and after (b) captopril treatment, DBP before (ᮀ) and after () captopril treatment and Discussion heart rate before (᭝) and after (̆) captopril treatment are shown.
In this study, slow-release nifedipine and captopril lowered the nocturnal systolic pressure, while acebutolol did not. The most prominent reduction in BP was seen nocturnally in the slow-release nifedipine group. It has been postulated that the decrease of the nocturnal BP is attributed to the decrease of the sympathetic tone. 4 Yet, the beta-blocking agents, acting primarily through the sympathetic nervous system, hardly affect the BP during the night. However, the calcium channel blockers, which have a direct effect on the peripheral vascular system, prominently lower the nocturnal BP. Some studies have suggested that the decline in BP caused by the presence of a blunted nocturnal BP may be the cause of target organ damages. 5 Although an excessive Figure 4 The changes of the BP and heart rate at four periods reduction in the BP of hypertensive patients with after administration of acebutolol. previous brain infarction during the night may contribute to stroke recurrence, there would have to be an appropriate reduction in nocturnal BP. For this reason, the nocturnal BP of patients with previous brain infarction must be checked. Of the three drugs, slow-release nifedipine and captopril significantly lowered the morning BP. Maler 6 reported after examining 1167 stroke patients, that stroke occurred most frequently from 10 am to noon. Raftery 7 postulated that the early morning rise in BP was due to intrinsic sympathetic activity mediated at the peripheral arteriole by alpha-adrenoceptors. Therefore, drugs that block beta-adrenoceptors did not influence BP this time. Kotake 8 reported that the acebutolol effectively Figure 5 The changes of the BP and heart rate at four periods blunted the early morning rise in BP of the patients after administration of slow-release nifedipine.
with essential hypertension. However in our study, the acebutolol did not significantly reduce the BP during the morning. Why? First, our patients may entire 24-h period. This reduction was most prominent during the period from 6 am to 11 am. The have more serious vascular damage compared to the patients without brain infarction. Second, our slow-release nifedipine produced a significant increase in the heart rate during the period from patients may have the involvement of the autonomic nervous system. Third, the dosage of acebutolol in 6 pm to 11 pm. Captopril produced a mild reduction in the BP with little change in the circadian pattern.
our study may be less than that in the previous reports. 9 We observed that captopril produced a Captopril produced a significant reduction in the BP during the period from 6 am to 11 am. Captopril did mild reduction in BP with little change in the circadian pattern. The mild captopril effect on BP may not show a significant change in the heart rate over the entire 24-h period. As shown in Table 3 , none of be explained by reduced dosage use in our study. 10 It is interesting that captopril produced a significant the antihypertensive agents affected the variability indexes of the systolic and diastolic BP, while only reduction in the BP during the morning although the amount of captopril may have been less than in the acebutolol produced a significant decrease in variability index of the heart rate.
previous studies. 
